Velarion · Company Intelligence
Compensation Brief
Fiscal year 2026 · Filings through 2026-08-28

Champions Oncology (CSBR)

Fiscal year 2026 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$3,567,022
Robert Brainin total, FY2026
CEO pay percentile vs peers
CEO-to-median pay ratio
99.93%
Say-on-pay support, latest vote
Companies that benchmark against CSBR
1 company names CSBR as a compensation peer

Each company listed discloses CSBR in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named CSBR in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

01

Summary Compensation Table — fiscal year 2026

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Robert Brainin$346,154$0$0$3,220,868$0$0$0$3,567,022
Chief Executive Officer
David Miller315,00025,000048,464000388,464
Chief Financial Officer
Ronnie Morris233,333000000233,333
Chief Executive Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2026 totalFY2025 totalFY2024 totalΔ FY20252026
Robert Brainin$3,567,022
David Miller388,464310,777315,777+77,687
Ronnie Morris233,333600,000600,000−366,667

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

02

Equity transactions since the proxy statement was filed

No insider equity transactions reported since the proxy statement.

04

Outstanding equity awards at fiscal year-end 2026

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Robert BraininOption150,0007.8
David MillerOption15,0005.72
Robert BraininOption225,0007.8
Robert BraininOption62,5007.8
Robert BraininOption100,0007.8
05

Incentive-plan design — the Compensation Discussion & Analysis

The Company’s executive compensation program reflects a variable pay-for-performance philosophy, utilizing several performance measures to align executive compensation with Company performance and generally seeking to incentivize long-term performance.

CEO STI target (% of salary)
CEO LTI target (% of salary)
Independent consultant
Clawback policytrue
Anti-hedging
Anti-pledging
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20252025-10-169,720,6817,26212299.93%Passed
20242024-10-149,162,2872,0273,90099.98%Passed
20232023-10-199,444,38510,040257,88799.89%Passed
20222022-10-209,025,63630,2353,55999.67%Passed
20212021-10-208,531,715103,13528,26998.81%Passed
20202020-10-218,475,330117,566139,21398.63%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20252025-10-1699.93%a
20242024-10-1499.98%b
20232023-10-1999.89%c

a. Voting standard not stated in the filing.

b. Voting standard not stated in the filing.

c. Voting standard not stated in the filing.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

07

CEO pay ratio

Ratio (CEO : median employee)
CEO total compensation
Median employee compensation
08

Director compensation — fiscal year 2026

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Joel AckermanIndependent · Audit · Nominating/Governance$0$0$98,226$0$98,226
Daniel MendelsonIndependent · Audit · Nominating/Governance · Compensation40,000055,225095,225
Scott R. TobinIndependent · Audit (Chair) · Compensation094,898094,898
Philip BreitfeldNot independent · Not standing for re-election · Departed during FY35,000051,402086,402
David SidranskyIndependent12,000069,890081,890
Ronnie MorrisNot independent · Board Chair75,0000075,000
Robert BraininEmployee director10,000030,622040,622
Brian AlexanderIndependent · Partial-year service · Newly elected015,764015,764
09

Board fee structure and ownership guideline

Annual cash retainer
Annual equity retainer
Per board meeting fee
Committee chair fees (audit / comp / nom-gov)
Stock ownership guideline
09b

Total cost of the board

ComponentFY2026
Cash retainers and fees$172,000
Equity awards (grant-date value)$0
All other compensation$0
Total cost of the board$172,000

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Champions Oncology2026Robert Brainin$346,154$0$3,220,868$0$3,567,022

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Robert BraininDEF 14A2026-08-280001628280-26-059373Section “Executive Compensation”. As printed: 3,567,022. Filing ↗
2Section 01, David MillerDEF 14A2026-08-280001628280-26-059373Section “Executive Compensation”. As printed: 388,464. Filing ↗
3Section 01, Ronnie MorrisDEF 14A2026-08-280001628280-26-059373Section “Executive Compensation”. As printed: 233,333. Filing ↗
4Section 07, pay ratio10-K2026-07-270001628280-26-049834Section “CEO Pay Ratio”. As printed: —. Filing ↗
5Section 08, Joel AckermanDEF 14A2026-08-280001628280-26-059373Section “Director Compensation”. As printed: 98,226. Filing ↗
6Section 08, Daniel MendelsonDEF 14A2026-08-280001628280-26-059373Section “Director Compensation”. As printed: 95,225. Filing ↗
7Section 08, Scott R. TobinDEF 14A2026-08-280001628280-26-059373Section “Director Compensation”. As printed: 94,898. Filing ↗
8Section 08, Philip BreitfeldDEF 14A2026-08-280001628280-26-059373Section “Director Compensation”. As printed: 86,402. Filing ↗
9Section 08, David SidranskyDEF 14A2026-08-280001628280-26-059373Section “Director Compensation”. As printed: 81,890. Filing ↗
10Section 08, Ronnie MorrisDEF 14A2026-08-280001628280-26-059373Section “Director Compensation”. As printed: 75,000. Filing ↗
11Section 08, Robert BraininDEF 14A2026-08-280001628280-26-059373Section “Director Compensation”. As printed: 40,622. Filing ↗
12Section 08, Brian AlexanderDEF 14A2026-08-280001628280-26-059373Section “Director Compensation”. As printed: 15,764. Filing ↗
13Section 06, 2025 voteForm 8-K2025-10-160001628280-25-045241Item 5.07 · say-on-pay result. As reported: 99.93% (votes for as printed: 9,720,681). Filing ↗
14Section 06, 2024 voteForm 8-K2024-10-150001628280-24-042780Item 5.07 · say-on-pay result. As reported: 99.98% (votes for as printed: 9,162,287). Filing ↗
15Section 06, 2023 voteForm 8-K2023-10-190001628280-23-034703Item 5.07 · say-on-pay result. As reported: 99.89% (votes for as printed: 9,444,385). Filing ↗
16Section 01 trend, Δ column (computed)ComputedcomputedΔ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1)
17Section 09b board cost (computed)ComputedcomputedCash 172,000 + equity 0 + all other 0 = 172,000, summed across the director compensation table rows.machine: formula: Σ = 172,000
18Champions Oncology (subject), Section 10b CEO totalDEF 14A2026-08-280001628280-26-059373CEO total compensation as printed in Champions Oncology's own proxy. As printed: 3,567,022. Filing ↗